新闻资讯
News Inforamtion
Noyuan Medical has successfully been selected as a (first-batch) innovative product of Nanjing City.
Release time:
2022-09-28
Recently, the Nanjing Municipal Bureau of Industry and Information Technology published the list of products selected for the first batch of Nanjing Innovative Products in 2022. Nuoyuan Medical’s “Endoscopic Fluorescence Imaging System,” thanks to its ultra-high-sensitivity innovative technology, was successfully included on the list.
Recently, the Nanjing Municipal Bureau of Industry and Information Technology published the list of products selected for the first batch of Nanjing Innovative Products in 2022. Nuoyuan Medical’s “Endoscopic Fluorescence Imaging System,” thanks to its ultra-high-sensitivity innovative technology, was successfully included on the list.
Highlights of the innovative product
This product exhibits high sensitivity for ICG detection and can identify sub-millimeter tumors in real time during surgery.
Exclusive product technology advantages of the “Endoscopic Fluorescence Imaging System”: Full-link 4K imaging, ultra-high-sensitivity molecular fluorescence, and a highly intelligent user experience.
1. Full-link 4K video footage
Provides 4K ultra-high-definition image quality across the entire link, with full coverage from the capture end to the output end (including endoscopes, camera optical paths, chip alignment, data transmission, displays, and recording systems)—a one-stop 4K solution.
With a color depth of 10 bits and compliance with the BT.2020 color space 4K standard, it delivers a wider dynamic color gamut. The high frame rate of 60 FPS ensures smooth, ultra-high-definition image output with low latency. The 4K resolution makes it easier to distinguish fine details such as blood vessels, nerves, and fascia layers, thereby enhancing surgical precision.
2. Ultra-sensitive molecular fluorescence
The independently developed near-infrared anti-reflection coating technology and the low-noise, weak-fluorescence channel have boosted the sensitivity of ICG detection to 4.88 × 10⁻¹⁰ mol/L, placing us at the forefront of the molecular fluorescence field.
Ultra-sensitive fluorescence enables the detection of ICG at ultra-low concentrations in tiny tumors, with a clinical detection limit as small as 0.288 mm for tumors, ushering tumor resection into an era of sub-millimeter precision surgery.
3. High-intelligence application experience
Intelligent algorithm-based low-glare technology effectively alleviates visual fatigue, reduces dizziness, and makes the surgeon’s work easier.
One-click switching between multi-channel images, automatic adjustment of wide dynamic range exposure, precise control of dual-spectrum light sources, and personalized parameter customization—making surgeries even more remarkable.
![[Good News] Nuoyuan Medical: Its 4K Endoscopic Fluorescence Imaging System Receives EU MDR Certification, Further Accelerating Its Internationalization Strategy.](https://omo-oss-image.thefastimg.com/portal-saas/pg2025081317413388999/cms/image/96290c1f-28bc-4e48-9627-a46f11761687.png "[Good News] Nuoyuan Medical: Its 4K Endoscopic Fluorescence Imaging System Receives EU MDR Certification, Further Accelerating Its Internationalization Strategy.")
Contact Us
Headquarters: Building Shengmingyuan, No. 18 Ziyun Avenue, Qinhuai District, Nanjing City
Factory: No. 18, Fuzhian South Road, Nanjing Fourth Bridge Economic Park, Liuhe District, Nanjing City
Email:yangliu@nuoyuanmedical.cn
Copyright © 2025 Nanjing Nuoyuan Medical Device Co., Ltd. All Rights Reserved.